» Articles » PMID: 38027184

Leydig Cell Metabolic Disorder Act As a New Mechanism Affecting for Focal Spermatogenesis in Klinefelter Syndrome Patients: a Real World Cross-sectional Study Base on the Age

Overview
Specialty Endocrinology
Date 2023 Nov 29
PMID 38027184
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Klinefelter's syndrome (KS) was once considered infertile due to congenital chromosomal abnormalities, but the presence of focal spermatozoa changed this. The key to predict and promote spermatogenesis is to find targets that regulate focal spermatogenesis.

Objective: To explore the trend of fertility changes in KS patients at different ages and identify potential therapeutic targets.

Methods: Bibliometric analysis was used to collect clinical research data on KS from the Web of Science Core Collection (WoSCC) from 1992 to 2022. A cross-sectional study was conducted on 75 KS patients who underwent microscopic testicular sperm extraction (mTESE) from 2017 to 2022 in the real world. The reproductive hormones, testicular histopathology, androgen receptors, insulin-like factor 3 (INSL3) receptors and sperm recovery rate (SRR) were analyzed.

Results: Male infertility, dysplasia, Sertoli cells, Leydig cells, testosterone and spermatogenesis were the research focuses related to KS. Luteinizing hormone (LH), testosterone, and INSL3 were evaluation indicators of Leydig cell function that fluctuate with age. Testosterone and LH peaked at ages 13-19 and 30-45, while INSL3 only peaked at ages 13-19. 27 patients (27/75) recovered sperm through mTESE and experienced SRR peaks at the ages of 20, 28, 34, and 37. The SRR of fibrosis patients was 46.15%, fatty degeneration was 7.14%, and melanosis was 40.00%. The INSL3 and androgen receptors were highly expressed and roughly balanced in focal spermatogenesis.

Conclusion: Abnormal metabolism of Leydig cells led to imbalanced expression of INSL3 and androgen receptors, which might be a potential target for spermatogenesis in KS.

Citing Articles

Serum Lipocalin-2 Levels as a Biomarker in Pre- and Post-Pubertal Klinefelter Syndrome Patients: A Pilot Study.

Paparella R, Ferraguti G, Fiore M, Menghi M, Micangeli G, Tarani F Int J Mol Sci. 2024; 25(4).

PMID: 38396890 PMC: 10889401. DOI: 10.3390/ijms25042214.

References
1.
Aksglaede L, Wikstrom A, Rajpert-De Meyts E, Dunkel L, Skakkebaek N, Juul A . Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Hum Reprod Update. 2005; 12(1):39-48. DOI: 10.1093/humupd/dmi039. View

2.
Ferhi K, Avakian R, Griveau J, Guille F . Age as only predictive factor for successful sperm recovery in patients with Klinefelter's syndrome. Andrologia. 2009; 41(2):84-7. DOI: 10.1111/j.1439-0272.2008.00875.x. View

3.
Plotton I, Renault L, Lapoirie M, Sanlaville D, Ecochard R, Giscard dEstaing S . Fertility in men with Klinefelter's syndrome. Ann Endocrinol (Paris). 2022; 83(3):172-176. DOI: 10.1016/j.ando.2022.05.002. View

4.
Berensztein E, Sciara M, Rivarola M, Belgorosky A . Apoptosis and proliferation of human testicular somatic and germ cells during prepuberty: high rate of testicular growth in newborns mediated by decreased apoptosis. J Clin Endocrinol Metab. 2002; 87(11):5113-8. DOI: 10.1210/jc.2002-020032. View

5.
Jan S, Jongejan A, Korver C, van Daalen S, van Pelt A, Repping S . Distinct prophase arrest mechanisms in human male meiosis. Development. 2018; 145(16). PMC: 6124541. DOI: 10.1242/dev.160614. View